Local Stories, Events
Ref. : Civic Events
Ref. : Arts & Education Events
Ref. : Public Service Notices
Books, Films, Arts & Education
12.11 This For-Profit College Is Leaving Students With Lots of Debt and No Degrees [It's a Trump University World]
Ref. : Letters to the editor
Health Care & Environment
12.11 The will of the people is to halt climate change, what about politicians? [Excellent!]
12.11 'We live in a lobstocracy': Maine town is feeling the effects of climate change [Do you care?]
12.11 Protesters disrupt pro-fossil fuel event at COP24 – video [Do you care?]
12.11 'It's a sad reality': a troubling trend sees a 97% decline in monarch butterflies [Do you care?]
News Media Matters
US Politics, Policy & 'Culture'
12.12 Trump reportedly flicked a folder and scattered papers in anger after his fiery debate with Nancy Pelosi and Chuck Schumer [His obsession for a $6 billion border wall is childish, considering all the better uses for such investment.]
12.12 How the IRS Was Gutted
12.12 The Sanders Institute's Gathering Was About Saving the World, But It Was Not About Bernie Sanders [a more detailed account]
12.11 2018 was by far the worst year on record for gun violence in schools [obviously, most politicians only care about "donations"]
12.11 'We Gonna Rise Up, Rise Up 'Til It's Won!': 140+ Arrested at Pelosi and Hoyer Offices as Youth-Led Protests Demand Green New Deal on Capitol Hill [Political Inaction or Citizen Rebellion, take your pick]
12.10 Paul Ryan’s long con
Economics, Crony Capitalism
International & Futurism
12.10 US and Russia ally with Saudi Arabia to water down climate pledge [The Oil Mafias lobby for more insanity]
Big Pharma Is the Big Winner in Health Care Reform
First published in his blog Unsilent Generation yesterday, 19 October 2009
As the Senate Finance Committee moved the legislation last week, the deal between the White House and PhRMA to limit price cuts to just $80 Billion out of $4 trillion seemed to be holding together just fine.
Big Pharma was the real winner in last week’s shouting match between Obama and the insurance industry. Insurance execs took all the heat for attacking the White House’s health care reform plan after the administration and lawmakers had negotiated for months to craft a proposal that the industry could live with. Meanwhile, Pharmaceutical Research and Manufacturers of America (PhRMA), the main industry umbrella group, got to play the good guy—all the while escaping scrutiny for the fact that in recent months it has been quietly jacking up drug prices.
Of course, Big Pharma already stands to hit the jackpot from Obama’s proposed reform plan. Under the deft direction of its chief lobbyist, former Louisiana congressman Billy Tauzin, PhRMA had already secured a valuable deal from the White House to provide a $80 billion in cost savings over the next 10 years in return for the President’s promise to oppose controls on drug pricing and importation of drugs from abroad.
As Fox’s Brian Sullivan points out, health care reform will increase the market for pharmaceuticals by tens of millions of people—a stock market bonanza:
But just in case someone throws a wrench into the deal, Big Pharma has been hedging its bets by quietly running up drug prices this year. The Pharmalot blog reports:
Of course, the White House could back out of its arrangement. But as the Senate Finance Committee moved the legislation last week, the deal seemed to be holding together just fine. Newsweek’s Howard Fineman explains how two attempts to ramp up funds from the drug industry were beaten—not by Republicans, but by Democrats:
Born in 1936, James Ridgeway has been reporting on politics for more than 45 years. He is currently Senior Washington Correspondent for Mother Jones, and recently wrote a blog on the 2008 presidential election for the Guardian online. He previously served as Washington Correspondent for the Village Voice; wrote for Ramparts and The New Republic; and founded and edited two independent newsletters, Hard Times and The Elements.
Ridgeway is the author of 16 books, including The Five Unanswered Questions About 9/11, It’s All for Sale: The Control of Global Resources, and Blood in the Face: The Ku Klux Klan, Aryan Nations, Nazi Skinheads, and the Rise of a New White Culture. He co-directed a companion film to Blood in the Face and a second documentary film, Feed, and has co-produced web videos for GuardianFilms.
Additional information and samples of James Ridgeway’s work can be found on his web site, http://jamesridgeway.net.
This article is republished in the Baltimore Chronicle with permission of the author.
Copyright © 2009 The Baltimore News Network. All rights reserved.
Republication or redistribution of Baltimore Chronicle content is expressly prohibited without their prior written consent.
Baltimore News Network, Inc., sponsor of this web site, is a nonprofit organization and does not make political endorsements. The opinions expressed in stories posted on this web site are the authors' own.This story was published on October 20, 2009.
Public Service Ads: